Chapel Hill, NCNCT06777901Now EnrollingIRB Ready

Peripheral Arterial Disease Clinical Trial in Chapel Hill, NC

Access cutting-edge peripheral arterial disease treatment through this clinical trial at a research site in Chapel Hill. Study-provided care at no cost to qualified participants.

Sponsored by Angiodynamics, Inc.

Quick Self-Assessment

See if you qualify for this Chapel Hill location

Preparing your pre-screening questions...

Expert Care in Chapel Hill

Access peripheral arterial disease specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related peripheral arterial disease treatment provided free

Apply for This Chapel Hill Location

Check if you qualify for this peripheral arterial disease clinical trial in Chapel Hill, NC

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Chapel Hill

    Convenient for NC residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Chapel Hill site if eligible
  4. 4Begin participation

About This Peripheral Arterial Disease Study in Chapel Hill

The goal of this clinical trial is to learn if the Auryon Atherectomy System with balloon angioplasty safe and effective in treating lower limb blockages. The main question it aims to answer is: Is treatment with Auryon Atherectomy System more effective than angioplasty alone in preventing death, amputation, revascularization and improving patency? Researchers will compare the Auryon Atherectomy System with balloon angioplasty to balloon angioplasty alone.

Sponsor: Angiodynamics, Inc.

Who Can Participate

Inclusion Criteria

Age of subject is ≥ 18.
Estimated life expectancy ≥1 year.
Subject is able and willing to comply with all assessments in the study.
Subject has been informed of the nature of the study, agrees to participate, and has signed the approved consent form.
Rutherford Category classification of 4 or 5 of the target limb.
Subject is a suitable candidate for angiography and endovascular intervention in the opinion of the investigator or per hospital guidelines. Angiographic Inclusion Criteria
Target lesion that is located in a native, de novo infra-popliteal artery (extending from P3 of the popliteal artery to the margin of the ankle mortise).
Target lesions(s) must be viewed angiographically and have 50-100% stenosis.
Only a single lesion is included in the study per subject.
The vessel segment distal to the target lesion must be patent all the way to the ankle, with no significant lesion (≥ 50% stenosis).
Lesion length ≥50mm and ≤300mm.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Chapel Hill?

Yes, this clinical trial (NCT06777901) has an active research site in Chapel Hill, NC that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Peripheral Arterial Disease Treatment Options in Chapel Hill, NC

If you're searching for peripheral arterial disease treatment options in Chapel Hill, NC, this clinical trial (NCT06777901) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Chapel Hill research site is actively enrolling participants for this clinical trial. You'll receive care from experienced peripheral arterial disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all peripheral arterial disease clinical trials near you to find additional studies recruiting in your area.

More Peripheral Artery Disease Trials in Chapel Hill, NC

See all peripheral artery disease clinical trials recruiting in Chapel Hill — not just this study.

Browse Peripheral Artery Disease Trials in Chapel Hill →

Browse More Trials by Condition

Peripheral Artery Disease TrialsPulmonary Embolism TrialsRheumatoid Arthritis TrialsAnkylosing Spondylitis TrialsPulmonary Hypertension TrialsAll Conditions →

Ready to Join in Chapel Hill?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Chapel Hill, NC